Parachute

Plasma Donation Servicesjoinparachute.com

Parachute operates a tech-enabled plasma donation platform across 51 centers in 17 U.S. states, paying individual donors through a mobile app with tiered compensation, and supplying collected plasma to fractionators for therapeutic processing.

Company typePrivate
Founded2021
HeadquartersAustin, United States
Headcount501–1,000
GTM typeB2C
OfferingServices

What Parachute does

Parachute (Join Parachute, LLC) is an Austin, Texas-based plasma donation company founded around 2021 that operates a technology-enabled platform for collecting source plasma. The company runs 51 physical donation centers across 17 U.S. states (with the heaviest presence in Texas at 11 centers, followed by North Carolina with 8 and Georgia with 6), generating revenue by paying donors for their plasma and selling the collected supply to fractionation facilities where it is processed into life-saving therapeutics. Its customers are individual donors—primarily adults aged 18–64 seeking supplemental income, including students, working adults, and retirees—acquired and retained primarily through a self-serve mobile app on iOS and Android.

The company's product stack centers on three components: a proprietary mobile app (developed by Buoy Software) that handles donor onboarding, scheduling, real-time availability, payments, referrals, and a 7-tier loyalty program in which donors earn higher per-donation rates based on donation frequency within a 30-day cycle; physical plasmapheresis centers where collection occurs via apheresis machines that return red blood cells and other components to the donor; and the Join Parachute Visa Prepaid Card, issued through Pathward, N.A., which delivers same-day payment via direct deposit. Donor pricing is transparent and disclosed on the website: $30–$40 per donation based on loyalty tier, with new-donor bonuses up to $200 across the first three visits, time-incentive bonuses of $1–$15, and referral payouts up to $70 per referred friend who reaches a new level; maximum annual donor earnings cap around $4,000 for those who donate twice weekly.

The business model is asset-heavy and consumer-direct: Parachute pays donors per donation (its primary cost of goods) and monetizes through the plasma supply chain to fractionators, positioning itself as a modern alternative to legacy plasma operators through mobile-first scheduling, no-wait-time service, and a hospitality-driven facility design. Capital-intensive infrastructure expansion is funded through venture backing totaling approximately $148.75M across multiple rounds, including a $36.28M exempt offering filed in June 2023 and a $38.15M raise in April 2026 that the company was reported as leading Texas venture deals for that week. The go-to-market relies on a product-led growth motion in which the app itself is the primary acquisition and retention surface, supported by content marketing, organic social presence, and an aggressive donor-referral mechanism.

Parachute firmographics

Firmographics

Name: Parachute
Legal name: Join Parachute, LLC
Website: https://joinparachute.com
Company type: Private
Founded year: 2021
Operating status: Operating
Headcount range: 501–1,000 employees
Short description: Parachute operates a tech-enabled plasma donation platform across 51 centers in 17 U.S. states, paying individual donors through a mobile app with tiered compensation, and supplying collected plasma to fractionators for therapeutic processing.
Ownership category
akta.pro rank

Parachute industry classification

Industry

Product category: Plasma Donation Services
akta.pro primary industry: Plasma Collection & Donor Services (Plasmapheresis Centers) (HLAIAHAH)

Keywords

Plasma donation services
Plasma collection centers
Donor compensation programs
Biopharmaceutical supply
Healthcare staffing

Where Parachute is headquartered

Location

Headquarters

HQ city: Austin
HQ country: United States
HQ region: North America

Offices1 record

Markets served

Parachute business model

Business model

GTM type: B2C
Offering type: Services
Cost components: Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain

Revenue model

Plasma Collection and Sale: Parachute collects plasma from donors and sells it to fractionation facilities where plasma proteins are extracted and turned into life-saving medicine. The company generates revenue from the plasma supply chain, paying donors per donation as a cost of goods.

Pricing tiers

Model	Billing	Price
Subscription	Per donation	New Donor Bonus - Up to $200 for first 3 donations
Unit Pricing	Per donation	Base Payment - $30 to $40 per donation based on loyalty level
Usage-based	Per donation	Time Incentive Bonuses - $1 to $15 per appointment
Transaction based/ take rate	Per referral event	Referral Program - Up to $70 per referral

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Parachute product offering

Product offering

Core offering

Parachute (Join Parachute, LLC) operates a network of plasma donation centers across the United States where individuals can donate plasma for compensation. The company uses plasmapheresis to collect plasma, which is then sold to fractionation facilities for the production of life-saving medicines. Donors are supported through a proprietary mobile application that enables appointment booking, real-time earnings tracking, and same-day compensation.

Product overview

Parachute operates as a plasma donation marketplace connecting donors with plasma collection centers through its proprietary mobile app. The core offering consists of the Parachute App (for scheduling, earnings management, and loyalty tracking) paired with a network of physical plasma donation centers across the U.S. Donors earn compensation per donation with payment delivered via the Join Parachute Visa Prepaid Card issued by Pathward. The platform uses a tiered loyalty system (7 levels) and offers bonus incentives through challenges and referrals.

Differentiator

Problem solved

Functional benefit

Products and services

Parachute Mobile App
Parachute Plasma Donation Centers

Quantifiable outcome

Up to $4,000 annual earnings for frequent donors
+3 more outcomes

Companies that use Parachute

Customer profile

Segments3 records

Ideal customer profiles1 record

Parachute technology and API

Technology

Technology focussed No

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Parachute partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Parachute competitors and assessment

Company assessment

Broad incumbents

CSL Plasma: CSL Plasma is the world's largest plasma collection network, operating 350+ centers across the U.S. and globally as a subsidiary of CSL Behring (a major fractionator). It is the dominant direct competitor to Parachute, with much greater scale, vertically integrated offtake, and brand recognition.
Grifols Plasma: Grifols operates 300+ plasma collection centers globally and is one of the largest integrated plasma fractionators. Directly comparable to Parachute in core donation activity, with the additional advantage of being a downstream fractionator buyer of its own and third-party plasma.

Direct peers

BioLife Plasma Services: BioLife operates 200+ U.S. plasma donation centers as a subsidiary of Takeda, supplying plasma for fractionation into therapeutics. It is the closest direct competitor to Parachute in target donor demographics, payment structure, and center-based collection model.
Octapharma Plasma: Octapharma Plasma operates 180+ donation centers in the U.S. and is part of Octapharma, a global fractionator. Direct head-to-head competitor to Parachute in donor acquisition, per-donation pricing, and center footprint expansion.
Kedrion (U.S. operations): Kedrion operates U.S. plasma collection centers feeding its fractionation business. Direct competitor in plasma collection with similar center-based, donor-compensated model, though smaller U.S. footprint than CSL/BioLife/Grifols.
BPL Plasma: BPL Plasma operates a growing U.S. donation center network tied to Bio Products Laboratory's fractionation business. Comparable as a smaller, scaling independent plasma collector competing in similar U.S. geographies.
Immunotek BioCenters: Immunotek operates a multi-state U.S. plasma donation center network. Comparable as a privately held, non-fractionator plasma collector competing for similar donor demographics in overlapping geographies.

Emerging players

ADMA BioCenters: ADMA BioCenters is a division of ADMA Biologics operating a smaller but growing U.S. plasma center network focused on specialty/special-immune plasma. Comparable to Parachute as an independent collector, though more vertically integrated into finished therapies.

Regional players

Plasma Biological Services / PlasmaSource: PlasmaSource operates regional plasma donation centers in select U.S. states. Comparable as a smaller regional collector; relevant for understanding geographic overlap and competition for donors in Parachute's footprint.

Others

Haemonetics: Haemonetics is a leading manufacturer of plasmapheresis collection devices and software (e.g., PCS2, NexSys PCS) used by plasma centers including Parachute. Not a direct competitor but a critical supplier/infrastructure provider whose technology Parachute's operations depend on.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Parachute financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Parachute leadership team

Management profile

Number of profiles

Profiles1 record

Parachute funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Parachute M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Parachute

What does Parachute do?

Is Parachute a public or private company?

Parachute is a private company. It is classified as venture growth investor backed and is currently operating.

When was Parachute founded?

Parachute was founded in 2021. It employs 501 to 1,000 people.

Where is Parachute based?

Parachute is headquartered in Austin, United States, in the North America region.

How does Parachute make money?

One revenue line is on record: plasma Collection and Sale.

Who are Parachute's main competitors?

Broad incumbents on record are CSL Plasma and Grifols Plasma. Direct peers are BioLife Plasma Services, Octapharma Plasma, Kedrion (U.S. operations), BPL Plasma and Immunotek BioCenters. ADMA BioCenters is listed as an emerging player. Plasma Biological Services / PlasmaSource is listed as a regional player. Haemonetics is listed as an others.

Does Parachute have an API?

No public API is recorded for Parachute.

What industry is Parachute in?

Parachute's product category is Plasma Donation Services. Its primary akta.pro industry code is HLAIAHAH, Plasma Collection & Donor Services (Plasmapheresis Centers).